219 related articles for article (PubMed ID: 27441413)
21. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
Roberts CJ; Stuhr KL; Hutz MJ; Raff H; Hillard CJ
Pharmacol Biochem Behav; 2014 Feb; 117():17-24. PubMed ID: 24316201
[TBL] [Abstract][Full Text] [Related]
22. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
23. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
Seillier A; Giuffrida A
Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
[TBL] [Abstract][Full Text] [Related]
24. Both CRF
Oliveira LA; Gomes-de-Souza L; Benini R; Wood SK; Crestani CC
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110009. PubMed ID: 32535028
[TBL] [Abstract][Full Text] [Related]
25. CRF
Oliveira LA; Almeida J; Gomes-de-Souza L; Benini R; Crestani CC
Eur J Neurosci; 2017 Jul; 46(2):1805-1812. PubMed ID: 28612996
[TBL] [Abstract][Full Text] [Related]
26. Role of the bed nucleus of the stria terminalis in the cardiovascular responses to acute restraint stress in rats.
Crestani CC; Alves FH; Tavares RF; Corrêa FM
Stress; 2009 May; 12(3):268-78. PubMed ID: 18850495
[TBL] [Abstract][Full Text] [Related]
27. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia.
Connell K; Bolton N; Olsen D; Piomelli D; Hohmann AG
Neurosci Lett; 2006 Apr; 397(3):180-4. PubMed ID: 16378681
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
Nawata Y; Yamaguchi T; Fukumori R; Yamamoto T
Int J Neuropsychopharmacol; 2019 Feb; 22(2):165-172. PubMed ID: 30481332
[TBL] [Abstract][Full Text] [Related]
29. The role of CB
Karwad MA; Couch DG; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
FASEB J; 2017 Aug; 31(8):3267-3277. PubMed ID: 28404744
[TBL] [Abstract][Full Text] [Related]
30. Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB(1) receptors.
Ferreira-Junior NC; Fedoce AG; Alves FH; Corrêa FM; Resstel LB
Am J Physiol Regul Integr Comp Physiol; 2012 Apr; 302(7):R876-85. PubMed ID: 22204950
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study.
Wiskerke J; Irimia C; Cravatt BF; De Vries TJ; Schoffelmeer AN; Pattij T; Parsons LH
ACS Chem Neurosci; 2012 May; 3(5):407-17. PubMed ID: 22860210
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
Nozaki C; Markert A; Zimmer A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
[TBL] [Abstract][Full Text] [Related]
33. Modulation of central endocannabinoid system results in gastric mucosal protection in the rat.
Tóth VE; Fehér Á; Németh J; Gyertyán I; Zádori ZS; Gyires K
Brain Res Bull; 2018 May; 139():224-234. PubMed ID: 29438780
[TBL] [Abstract][Full Text] [Related]
34. Endocannabinoid degradation inhibitors ameliorate neuronal and synaptic alterations following traumatic brain injury.
Fucich EA; Stielper ZF; Cancienne HL; Edwards S; Gilpin NW; Molina PE; Middleton JW
J Neurophysiol; 2020 Feb; 123(2):707-717. PubMed ID: 31913777
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
[TBL] [Abstract][Full Text] [Related]
36. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
Biernacki M; Łuczaj W; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
Toxicol Appl Pharmacol; 2016 Jun; 301():31-41. PubMed ID: 27086176
[TBL] [Abstract][Full Text] [Related]
37. Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses.
Batista LA; Bastos JR; Moreira FA
J Psychopharmacol; 2015 Mar; 29(3):335-43. PubMed ID: 25601395
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
39. Processing cardiovascular information in the vlPAG during electroacupuncture in rats: roles of endocannabinoids and GABA.
Tjen-A-Looi SC; Li P; Longhurst JC
J Appl Physiol (1985); 2009 Jun; 106(6):1793-9. PubMed ID: 19325030
[TBL] [Abstract][Full Text] [Related]
40. Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress.
Bedse G; Colangeli R; Lavecchia AM; Romano A; Altieri F; Cifani C; Cassano T; Gaetani S
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1511-23. PubMed ID: 25106694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
